Pharmaceuticals
Monthly Update6 April 2026 at 12:21 pm

Syncom Formulations India Ltd: Promoters Disclose Yearly Securities Disclosure

AI Summary

Syncom Formulations India Ltd. has received the Yearly Disclosure for the financial year ended on 31st March, 2026 from its promoters - Shri Kedarmal Shankarlal Bankda and Shri Vijay Shankarlal Bankda, along with their Persons Acting in Concert (PAC). The disclosure, as per Regulation 31(4) of SEBI (SAST) Regulations, 2011, has been submitted to the Audit Committee of the Company, BSE Limited, and National Stock Exchange of India Limited. The promoters have declared no encumbrance in the securities of Syncom Formulations (India) Limited, other than those already disclosed during the Financial Year ended on 31st March, 2026.

Key Highlights

  • Syncom Formulations India Ltd. received Yearly Disclosure from promoters Shri Kedarmal Shankarlal Bankda and Shri Vijay Shankarlal Bankda.
  • Disclosure submitted to Audit Committee, BSE, and NSE as per Regulation 31(4) of SEBI (SAST) Regulations, 2011.
  • Promoters and PAC have declared no encumbrance in the securities of Syncom Formulations (India) Limited.
  • Encumbrances already disclosed during the Financial Year ended on 31st March, 2026, have been acknowledged.